NCT05823701 2023-04-21
Chidamide, Azacitidine Combined With GM Regimen for Relapsed and Refractory DLBCL Patients
The First Affiliated Hospital of Soochow University
Phase 2 Unknown
Clinical Trials
7 trialsNCT05797948 2023-04-04
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
Phase NA Unknown
NCT05322733 2022-04-19
Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Unknown
NCT04934930 2021-06-22
FLMRD
Meir Medical Center
Phase 2 Unknown
NCT02689869 2021-05-07
Alternative
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT04059081 2019-08-16
A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assessment
Chonnam National University Hospital
Phase 2 Unknown
NCT03679455 2018-11-13
OBI-1
Polish Myeloma Consortium
Phase 2 Unknown